Literature DB >> 15243112

Differences in clinical manifestation of Streptococcus pneumoniae infection are not correlated with in vitro production and release of the virulence factors pneumolysin and lipoteichoic and teichoic acids.

Annette Spreer1, Astrid Lis, Joachim Gerber, Ralf René Reinert, Helmut Eiffert, Roland Nau.   

Abstract

Production and release of the pneumococcal virulence factors pneumolysin and lipoteichoic and teichoic acid in 75 clinical isolates were investigated. No difference was found between strains causing systemic infection or localized respiratory infection and isolates from asymptomatic carriers. This suggests that the presence of pneumolysin and lipoteichoic and teichoic acid is a necessary but not a sufficient condition for pneumococcal infection and development of invasive disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243112      PMCID: PMC446287          DOI: 10.1128/JCM.42.7.3342-3345.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.

Authors:  P Balachandran; S K Hollingshead; J C Paton; D E Briles
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis.

Authors:  Johann S Braun; Jack E Sublett; Dorette Freyer; Tim J Mitchell; John L Cleveland; Elaine I Tuomanen; Joerg R Weber
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  A specific and ultrasensitive chemiluminescent sandwich ELISA test for the detection and quantitation of pneumolysin.

Authors:  M D Cima-Cabal; F J Méndez; F Vázquez; M del Mar García-Suárez; J R de los Toyos
Journal:  J Immunoassay Immunochem       Date:  2001

4.  Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency.

Authors:  R A Hirst; K S Sikand; A Rutman; T J Mitchell; P W Andrew; C O'Callaghan
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase.

Authors:  Argyrios K Stringaris; Jens Geisenhainer; Friederike Bergmann; Christoph Balshüsemann; Unaa Lee; Gregor Zysk; Timothy J Mitchell; Bernhard U Keller; Ulrich Kuhnt; Joachim Gerber; Annette Spreer; Mathias Bähr; Uwe Michel; Roland Nau
Journal:  Neurobiol Dis       Date:  2002-12       Impact factor: 5.996

Review 6.  The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection.

Authors:  Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Curr Opin Infect Dis       Date:  2002-06       Impact factor: 4.915

Review 7.  Pneumococcal virulence factors: structure and function.

Authors:  M J Jedrzejas
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 8.  Role of lipoteichoic acid in infection and inflammation.

Authors:  Isaac Ginsburg
Journal:  Lancet Infect Dis       Date:  2002-03       Impact factor: 25.071

9.  Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin.

Authors:  K Stuertz; H Schmidt; H Eiffert; P Schwartz; M Mäder; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

10.  The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro.

Authors:  C Feldman; R Anderson; R Cockeran; T Mitchell; P Cole; R Wilson
Journal:  Respir Med       Date:  2002-08       Impact factor: 3.415

View more
  1 in total

1.  Performance of a pneumolysin enzyme-linked immunosorbent assay for diagnosis of pneumococcal infections.

Authors:  María del Mar García-Suárez; María Dolores Cima-Cabal; Roberto Villaverde; Emma Espinosa; Miquel Falguera; Juan R de Los Toyos; Fernando Vázquez; Francisco J Méndez
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.